Avelumab first-line (1L) maintenance + best supportive care (BSC) vs BSC alone for advanced urothelial carcinoma (UC): Association between clinical outcomes and exploratory biomarkers
Powles, T.B., Loriot, Y., Bellmunt, J., Sternberg, C.N., Sridhar, S., Petrylak, D.P., Tambaro, R., Dourthe, L.M., Alvarez-Fernandez, C., Aarts, M., Mu, X.J., Ching, K.A., Pu, J., Roychoudhury, S., DavVolume:
31
Journal:
Annals of Oncology
DOI:
10.1016/j.annonc.2020.08.771
Date:
September, 2020
File:
PDF, 103 KB
2020